 Home > Biochemistry News > Biotechnology News > Innovative blood test to diagnose Alzheimer's disease was recognized as a breakthrough medical device by the FDA

Innovative blood test to diagnose Alzheimer's disease was recognized as a breakthrough medical device by the FDA

 Last Update: 2021-11-05
 Source: Internet
 Author: User

Tags

sites

dragon's blood resin

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On October 12, 2021, Quanterix announced that its blood test Simoa phospho-Tau 181 (pTau-181) has been granted a breakthrough medical device designation by the US FDA to assist in the diagnosis of Alzheimer's disease (AD)

Simoa pTau-181 is a semi-quantitative immunoassay method that measures the concentration of pTau-181 in the serum and plasma of patients

The Simoa pTau-181 detection kit targets the proline-rich region of Tau protein, which is highly conserved among these subtypes

▲Quanterix's technology platform can detect low abundance/concentration biomarkers in the blood (picture source: Quanterix's official website)

Reference materials:

[1] Quanterix Granted Breakthrough Device Designation from US FDA for Blood-Based pTau-181 Assay for Alzheimer's Disease.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Courier blood test to diagnose Alzheimer's disease, innovative test was recognized by FDA as a breakthrough medical device

10-21

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.

Innovative blood test to diagnose Alzheimer's disease was recognized as a breakthrough medical device by the FDA

Related Articles

Courier blood test to diagnose Alzheimer's disease, innovative test was recognized by FDA as a breakthrough medical device